News Update: Savient Pharmaceuticals Jumps 27% on FDA Approval for Gout Drug

Published April 23, 2014

News Update: Savient Pharmaceuticals Jumps 27% On FDA Approval For Gout Drug — Savient Pharmaceuticals (NASDAQ:SVNT) surged over 27% premarket on news that the FDA approved its gout drug for adults who could not tolerate, or were unable…

European Commission Grants Orphan Drug Designation to Soliris® (Eculizumab …
Soliris is approved in the U.S. (2007), European Union (2007), Japan (2010) and other countries as the first and only treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), a debilitating, ultra-rare and life-threatening blood disorder, …
Read more on The Herald | HeraldOnline.com (press release)

Lawmakers to Examine Rehab of Mentally Ill, Addicted Inmates
A study in 2010 by researchers at the University of Texas Medical Branch in Galveston that examined a sample of Texas parolees with a dual diagnosis of a major psychiatric disorder and a substance abuse disorder found that the group had a …
Read more on Texas Tribune

More Drug Treatment News 2010 Information…